SCHEMBL19984764

SCHEMBL19984764

Nc1cnccc1Sc1ccccc1C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.58
TDP1 Q9NUW8 3/20 0.58
ALDH1A1 P00352 3/20 0.58
KDM4C Q9H3R0 3/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
KDM4D Q6B0I6 2/20 0.56
MEN1 O00255 1/20 0.56
KDM6B O15054 1/20 0.56
KDM4A O75164 1/20 0.56
MAPT P10636 1/20 0.56
THRB P10828 1/20 0.56
KMT2A Q03164 1/20 0.56
SLC22A12 Q96S37 1/20 0.54
POLB P06746 2/20 0.47
PKM P14618 3/20 0.43
RAB9A P51151 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19975056 0.83 ALDH1A1 (0.60) KDM4EALDH1A1MAPTKMT2APOLB
SCHEMBL2032649 0.82 KDM4E (0.71) KDM4ETDP1ALDH1A1L3MBTL1MEN1
Hydrochloric Acid SCHEMBL2909102 0.80 KDM4E (0.69) KDM4ETDP1ALDH1A1L3MBTL1MEN1
SCHEMBL29888792 0.78 POLB (0.74) KDM4ETDP1ALDH1A1L3MBTL1MAPT
SCHEMBL1482567 0.78 POLB (0.74) KDM4ETDP1ALDH1A1L3MBTL1MAPT
SCHEMBL9460748 0.76 POLB (0.71) KDM4ETDP1ALDH1A1L3MBTL1MAPT
SCHEMBL29269659 0.75 SLC22A12 (0.67) KDM4ETDP1ALDH1A1KDM4CMEN1
SCHEMBL16702318 0.75 PTGS1 (0.46) KDM4ETDP1ALDH1A1KDM4CL3MBTL1
SCHEMBL17080193 0.75 KDM4E (0.75) KDM4ETDP1ALDH1A1L3MBTL1MEN1
SCHEMBL29441695 0.75 KDM4E (0.75) KDM4ETDP1ALDH1A1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2022-01-27 US disclosed
US-10987360-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2021-04-27 US disclosed
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2019-08-22 US disclosed
WO-2018053157-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10987360-B2 Hepatitis B core protein modulators HAVCR2, FABP1, MAVS KDM4E 2469/4885TDP1 4608/4885ALDH1A1 3992/4885
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS KDM4E 2469/4885TDP1 4608/4885ALDH1A1 3992/4885
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS KDM4E 2469/4885TDP1 4608/4885ALDH1A1 3992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.